Bausch Health Companies (BHC) R&D In Process (2016 - 2019)
Historic R&D In Process for Bausch Health Companies (BHC) over the last 10 years, with Q1 2019 value amounting to $1.0 million.
- Bausch Health Companies' R&D In Process changed 0.0% to $1.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $18.0 million, marking a year-over-year decrease of 4705.88%. This contributed to the annual value of $1.0 million for FY2018, which is 8000.0% down from last year.
- As of Q1 2019, Bausch Health Companies' R&D In Process stood at $1.0 million, which was down 0.0% from $1.0 million recorded in Q1 2018.
- In the past 5 years, Bausch Health Companies' R&D In Process registered a high of $95.8 million during Q3 2015, and its lowest value of -$20.0 million during Q4 2016.
- For the 4-year period, Bausch Health Companies' R&D In Process averaged around $16.2 million, with its median value being $1.0 million (2016).
- Its R&D In Process has fluctuated over the past 5 years, first surged by 38140.7% in 2015, then tumbled by 85238.1% in 2016.
- Bausch Health Companies' R&D In Process (Quarter) stood at -$2.1 million in 2015, then tumbled by 852.38% to -$20.0 million in 2016, then soared by 105.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
- Its R&D In Process was $1.0 million in Q1 2019, compared to $1.0 million in Q1 2018 and -$20.0 million in Q4 2016.